✦ LIBER ✦

Escitalopram for the prevention of peginterferon alpha-2a- and ribavirin-associated depression in HCV-infected patients without prior psychiatric disease: A randomized controlled trial

✍ Scribed by Martin Schaefer; Rahul Sarkar; Viola Weich; Susanne Effenberger; Astrid Friebe; Loni Heinze; Ulrich Spengler; Thomas Schläpfer; Jens Reimer; Peter Buggisch; Johann Ockenga; Ralph Link; Michael Rentrop; Hans Weidenbach; Gwendolyn Fromm; Klaus Lieb; Thomas F. Baumert; Andreas Heinz; Thomas Discher; Konrad Neumann; Stefan Zeuzem; Thomas Berg

Book ID: 113824202
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 159 KB
Volume: 18
Category: Article
ISSN: 0941-9500
DOI: 10.1016/j.npbr.2012.02.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

607 EFFICACY AND SAFETY OF ESCITALOPRAM

607 EFFICACY AND SAFETY OF ESCITALOPRAM FOR PREVENTION OF DEPRESSIVE SYMPTOMS INDUCED BY PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN CHRONIC HEPATITIS C. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

✍ C. Diez-Quevedo; H. Masnou; P. Castellví; R.M. Morillas; M.D. Giménez; R. Solá; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

298 ESCITALOPRAM FOR THE PREVENTION OF P

298 ESCITALOPRAM FOR THE PREVENTION OF PEG-IFN-α AND RIBAVIRIN ASSOCIATED DEPRESSION IN HCV-INFECTED PATIENTS: FINAL RESULTS FROM THE CIPPAD-TRIAL

✍ M. Schaefer; R. Sarkar; V. Weich; S. Effenberger; L. Heinze; U. Spengler; T. Sch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB